P&T Perspectives

Real P&T Professionals. Real Market Research.

Exposing potential obstacles through market research with unbiased and objective insights from P&T decision-makers is critical.

MMIT P&T Perspectives provides qualitative and tangible feedback through a realistic simulated P&T session that informs your individual brand strategy and enables you to understand how your product and/or competitor’s product will fare in an actual P&T Committee review.

Learn More


icon

Predict

Predict how a P&T Committee might evaluate your drug against competitors.

icon

Understand

Understand how pricing could impact your drug’s placement on formulary.

icon

Identify

Identify the types of coverage restrictions that could be placed on your therapy and competitors.

icon

Improve

Improve your drug’s launch trajectory by identifying the most competitive contracting scenarios.

Features

How We Help

MMIT's industry-leading P&T panel consists of pharmacy decision-makers at health plans, PBMs, providers and integrated delivery systems. 100% of panelists are either active P&T participants or control access for pharmaceuticals for their organizations, giving you unparalleled visibility into these entities.

Simulate

Simulate a typical payer or IDN P&T committee, including a pharmacy director, medical director, contracting executives, and physicians and disease state specialists.

Analyze

Analyze a clinical dossier developed autonomously by a clinical pharmacist, with the opportunity to provide additional clinical data and/or target product profile.

Increase Efficiency

Increase rebate processing team efficiency.

Reduce Leakage

Reduce rebate leakage and protect millions of dollars from leaving your organization due to incorrect formulary and medical benefit positioning.

Improve Reach

Conduct more comprehensive contract evaluation.

Observe

Observe a 90 minute live-streamed session, including a 45 minute clinical overview and discussion based on the clinical dossier and a 45 minute financial overview and discussion led by the contracting pharmacist.

Question

Ask specific questions of the double-blinded participants during a 15-minute Q&A session after the P&T meeting concludes.

Minimize Errors

Minimize data inaccuracies and human-made errors.

Showcase 1
PlayPlay
Showcase 1
PlayPlay
Showcase 1
PlayPlay
Showcase 1
PlayPlay
previous arrowprevious arrow
previous arrowprevious arrow
next arrownext arrow
next arrownext arrow
Slide 1
pt-perspectives-brochure
target-icon
desktop-data-icon
data-icon

Discover More About P&T Perspectives

MMIT P&T Perspectives provides qualitative and tangible feedback through a realistic simulated P&T session that informs your individual brand strategy and enables you to understand how your product and/or competitor’s product will fare in an actual P&T Committee review. Learn more by downloading our brochure!

Slide 3

WHATS NEW

Keep Up-to-Date With Key Insights From MMIT

syndicated-pt-session

Syndicated P&T Session

A pharma company with several approved brands with large market share was developing a new Crohn’s disease drug. The company partnered with MMIT to determine whether the new drug would be approved in the marketplace.

prepare-launch-pt-perspectives

Preparing for Launch with P&T Perspectives

Learn how a P&T review helped one pharma company understand how its product would be assessed, leading to a new focus on gathering real-world evidence.

understand-impact-humira-biosimilars

Understanding the Impact of Humira Biosimilars on Market Access

Explore how we can expect the market to react and how factors such as launch timing, interchangeability, and contracting will shape the immunology landscape.

Slide 2

RELATED SOLUTIONS

Solutions to Support Your Strategy
analytics

Analytics

As the leading platform for pharma market access teams, MMIT Analytics analyzes comprehensive formulary, policy and restriction information to evaluate patient access for your brands, competitors and analogs.

message-monitor

Message Monitor

Use Message Monitor to capture key payer and IDN decision-makers’ insights around brand perception so you can better position your product against the competition.

Slide 2

RELATED SOLUTIONS

Solutions to Support Your Strategy
strategic-launch-report

Strategic Launch Report

MMIT launch reports help manufacturers vet potential analog products, outline payer and channel segmentation, and highlight potential restrictions to drug launch policies, speeding up commercialization.

rapid-response

Rapid Response

Improve your brand strategy with Rapid Response’s quick, actionable answers to key business questions among a representative sample of the payer and IDN stakeholders that you care about.

previous arrowprevious arrow
previous arrowprevious arrow
next arrownext arrow
next arrownext arrow